Gloucester Pharmaceuticals, Inc.

Joseph S. Mohr named president and CEO of cancer therapeutics company

Published in Oncology Business Week, May 16th, 2004

Gloucester Pharmaceuticals, Inc., a privately held cancer therapeutics development company, announced that Joseph S. "Jay" Mohr has been appointed president and CEO, and a director, of the company.

Founded in 2003, Gloucester develops and commercializes innovative clinical and pre-investigational new drug application-stage products for the treatment of cancer. Apple Tree Partners, an early-stage, life sciences venture capital fund, provided the initial funding for the company.

"Jay's extensive business development and product marketing experience in both the pharmaceutical and biotechnology industries provides him with an ideal background to run a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Oncology Business Week

Source: Oncology Business Week (2004-05-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry